title: Yeast as a potential vehicle for neglected tropical disease drug discovery.
abstract: High-throughput screening (HTS) efforts for neglected tropical disease (NTD) drug discovery have recently received increased attention because several initiatives have begun to attempt to reduce the deficit in new and clinically acceptable therapies for this spectrum of infectious diseases. HTS primarily uses two basic approaches, cell-based and in vitro target-directed screening. Both of these approaches have problems; for example, cell-based screening does not reveal the target or targets that are hit, whereas in vitro methodologies lack a cellular context. Furthermore, both can be technically challenging, expensive, and difficult to miniaturize for ultra-HTS [(u)HTS]. The application of yeast-based systems may overcome some of these problems and offer a cost-effective platform for target-directed screening within a eukaryotic cell context. Here, we review the advantages and limitations of the technologies that may be used in yeast cell-based, target-directed screening protocols, and we discuss how these are beginning to be used in NTD drug discovery.
authors.affiliation: Biophysical Sciences Institute, Department of Chemistry and School of Biological Sciences, University Science Laboratories, Durham, UK School of Medicine, Pharmacy and Health, Durham University, Durham, UK p.w.denny@durham.ac.uk.
authors.forename: P W
authors.initials: PW
authors.lastname: Denny
authors.affiliation: Biophysical Sciences Institute, Department of Chemistry and School of Biological Sciences, University Science Laboratories, Durham, UK.
authors.forename: P G
authors.initials: PG
authors.lastname: Steel
mesh_terms: D055808:Drug Discovery; D004353:Drug Evaluation, Preclinical; D057166:High-Throughput Screening Assays; D006801:Humans; D058069:Neglected Diseases / Q000188:drug therapy*; D014330:Tropical Medicine; D015003:Yeasts
keywords: high-throughput screening; neglected tropical diseases; yeast